Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine for Postoperative Pain in Total Laparoscopic Hysterectomy
NCT07435909Recruiting
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms). Primary endpoint: Visual Analog Scale for Pain at 24 hours. Started Aug 2025; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07435909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435909.